SPY334.57+0.24 0.07%
DIA274.62+0.72 0.26%
IXIC11,010.98-97.09 -0.87%

BMO Capital Maintains Market Perform on Amneal Pharmaceuticals, Lowers Price Target to $4

BMO Capital maintains Amneal Pharmaceuticals (NYSE:AMRX) with a Market Perform and lowers the price target from $5 to $4.

Benzinga · -

BMO Capital maintains Amneal Pharmaceuticals (NYSE:AMRX) with a Market Perform and lowers the price target from $5 to $4.